A detailed history of Geode Capital Management, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,668,358 shares of IONS stock, worth $97.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,668,358
Previous 2,484,544 7.4%
Holding current value
$97.5 Million
Previous $118 Million 9.73%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$40.06 - $51.86 $7.36 Million - $9.53 Million
183,814 Added 7.4%
2,668,358 $107 Million
Q2 2024

Aug 09, 2024

BUY
$36.45 - $47.7 $4.38 Million - $5.74 Million
120,288 Added 5.09%
2,484,544 $118 Million
Q1 2024

May 13, 2024

BUY
$42.03 - $53.55 $3.71 Million - $4.73 Million
88,325 Added 3.88%
2,364,256 $102 Million
Q4 2023

Feb 13, 2024

BUY
$43.39 - $51.63 $3.52 Million - $4.19 Million
81,200 Added 3.7%
2,275,931 $115 Million
Q3 2023

Nov 13, 2023

BUY
$38.5 - $47.13 $1.46 Million - $1.78 Million
37,863 Added 1.76%
2,194,731 $99.6 Million
Q2 2023

Aug 11, 2023

BUY
$34.73 - $43.33 $3.02 Million - $3.77 Million
86,918 Added 4.2%
2,156,868 $88.5 Million
Q1 2023

May 15, 2023

BUY
$33.58 - $41.2 $1.92 Million - $2.36 Million
57,227 Added 2.84%
2,069,950 $74 Million
Q4 2022

Feb 13, 2023

BUY
$37.12 - $46.52 $4.14 Million - $5.19 Million
111,580 Added 5.87%
2,012,723 $76 Million
Q3 2022

Nov 14, 2022

BUY
$36.54 - $48.66 $1.32 Million - $1.75 Million
36,010 Added 1.93%
1,901,143 $84.1 Million
Q2 2022

Aug 12, 2022

SELL
$31.71 - $43.0 $1.03 Million - $1.39 Million
-32,359 Reduced 1.71%
1,865,133 $69 Million
Q1 2022

May 13, 2022

BUY
$29.88 - $37.04 $2.16 Million - $2.68 Million
72,266 Added 3.96%
1,897,492 $70.3 Million
Q4 2021

Feb 11, 2022

BUY
$25.61 - $35.1 $1.34 Million - $1.84 Million
52,459 Added 2.96%
1,825,226 $55.5 Million
Q3 2021

Nov 12, 2021

BUY
$33.54 - $40.55 $343,013 - $414,704
10,227 Added 0.58%
1,772,767 $59.5 Million
Q2 2021

Aug 13, 2021

BUY
$34.54 - $47.25 $1.15 Million - $1.58 Million
33,394 Added 1.93%
1,762,540 $70.3 Million
Q1 2021

May 12, 2021

BUY
$42.51 - $63.78 $2.42 Million - $3.63 Million
56,942 Added 3.41%
1,729,146 $77.6 Million
Q4 2020

Feb 12, 2021

BUY
$45.3 - $60.27 $3.71 Million - $4.94 Million
81,910 Added 5.15%
1,672,204 $94.4 Million
Q3 2020

Nov 13, 2020

BUY
$47.45 - $62.95 $2.68 Million - $3.56 Million
56,509 Added 3.68%
1,590,294 $75.4 Million
Q2 2020

Aug 13, 2020

BUY
$46.85 - $61.05 $2 Million - $2.61 Million
42,720 Added 2.87%
1,533,785 $90.4 Million
Q1 2020

May 14, 2020

BUY
$41.6 - $63.4 $1.97 Million - $3 Million
47,323 Added 3.28%
1,491,065 $70.4 Million
Q4 2019

Feb 13, 2020

BUY
$53.85 - $65.27 $845,714 - $1.03 Million
15,705 Added 1.1%
1,443,742 $87.1 Million
Q3 2019

Nov 12, 2019

SELL
$59.06 - $72.15 $7.91 Million - $9.67 Million
-133,960 Reduced 8.58%
1,428,037 $85.5 Million
Q2 2019

Aug 14, 2019

BUY
$62.09 - $86.14 $9.01 Million - $12.5 Million
145,075 Added 10.24%
1,561,997 $100 Million
Q1 2019

May 14, 2019

BUY
$52.92 - $81.17 $3.99 Million - $6.13 Million
75,489 Added 5.63%
1,416,922 $115 Million
Q4 2018

Feb 13, 2019

BUY
$43.37 - $59.54 $3.56 Million - $4.89 Million
82,152 Added 6.52%
1,341,433 $72.5 Million
Q3 2018

Nov 13, 2018

BUY
$42.88 - $53.7 $4.48 Million - $5.61 Million
104,516 Added 9.05%
1,259,281 $65 Million
Q2 2018

Aug 14, 2018

BUY
$40.53 - $50.7 $2.5 Million - $3.13 Million
61,723 Added 5.65%
1,154,765 $48.1 Million
Q1 2018

May 15, 2018

BUY
$44.08 - $55.05 $833,640 - $1.04 Million
18,912 Added 1.76%
1,093,042 $48.2 Million
Q4 2017

Feb 13, 2018

BUY
$50.3 - $64.39 $1.23 Million - $1.58 Million
24,499 Added 2.33%
1,074,130 $54 Million
Q3 2017

Nov 14, 2017

BUY
$45.56 - $59.57 $1.02 Million - $1.34 Million
22,431 Added 2.18%
1,049,631 $53.2 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,027,200
1,027,200 $52.3 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.19B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.